as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
5.04%
Downside
2.49%
Upside
52 Week's Low
52 Week's High
85.11%
Downside
9.30%
Upside
Check Maze Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
-3.0696
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-52.69%
Compare market cap, revenue, PE, and other key metrics of Maze Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $2.1B | NA | NA | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
The Maze Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Maze Therapeutics investment value today
Current value as on today
₹3,40,080
Returns
₹2,40,080
(+240.08%)
Returns from Maze Therapeutics Stock
₹2,36,771 (+236.77%)
Dollar Returns*
₹3,309 (+3.31%)
Search interest for Maze Therapeutics Stock has increased by 271% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:271% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, MAZE stock has moved up by 57.4%
Best in 1 Year
![]()
In the last 1 year, MAZE has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Maze Therapeutics |
| Headquarters | 171 Oyster Point Blvd, South San Francisco, CA, United States, 94080 |
| CEO | Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Matt Krause | Senior Vice President of Human Resources |
Ms. Nazila Habibizad | Senior Vice President of Technical Operations & Supply Chain |
Mr. Maarten Hoek | Senior Vice President of Research |
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D. | CEO & Director |
Dr. Harold S. Bernstein M.D., Ph.D. | President of Research & Development and Chief Medical Officer |
Ms. Courtney J. Phillips J.D. | General Counsel & Corporate Secretary |
Mr. Misbah Tahir CPA | Chief Financial Officer |
Mr. Vipin Vijayakumar | Vice President of R&D Infrastructure and Operations |
Mr. Atul Dandekar | Chief Strategy & Business Officer |
Ms. Amy Bachrodt | Senior Vice President of Finance |
Maze Therapeutics share price today is $45.06 as on at the close of the market. Maze Therapeutics share today touched a day high of $46.18 and a low of $42.79.
Maze Therapeutics share touched a 52 week high of $49.25 on and a 52 week low of $6.71 on . Maze Therapeutics stock price today i.e. is closed at $45.06,which is 8.51% down from its 52 week high and 571.54% up from its 52 week low.
Maze Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Maze Therapeutics (MAZE) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Maze Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Maze Therapeutics share’s latest price of $45.06 as on February 7, 2026 at 2:29 am IST, you will get 0.2219 shares of Maze Therapeutics. Learn more about
fractional shares .